HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
Huagongshe Open Program:[email protected]AI access: llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.7.9
  1. Home
  2. /Compound

Glycyrrhetinic Acid

HCID 10114
New noteNew reactionRequest quotesPrint preview
Basic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
471-53-4
Standard SMILES
CC1(C)[C@@H](O)CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@@](C)(C(=O)O)CC[C@]5(C)CC[C@@]4(C)[C@]3(C)CC[C@@H]12
InChIKey
MPDGHEJMBKOTSU-YKLVYJNSSA-N
Molecular formula
C30H46O4
Average molar mass
470.7 g/mol
Monoisotopic mass
470.33960994

Overview

Glycyrrhetinic acid is a pentacyclic triterpenoid that is olean-12-ene substituted by a hydroxy group at position 3, an oxo group at position 11 and a carboxy group at position 30. It has a role as an immunomodulator and a plant metabolite. It is a pentacyclic triterpenoid, a hydroxy monocarboxylic acid and a cyclic terpene ketone. It is a conjugate acid of a glycyrrhetinate. It derives from a hydride of an oleanane.

Names & identifiers

Preferred name
Glycyrrhetinic Acid
IUPAC
(2S,4aS,6aR,6aS,6bR,8aR,10S,12aS,14bR)-10-hydroxy-2,4a,6a,6b,9,9,12a-heptamethyl-13-oxo-3,4,5,6,6a,7,8,8a,10,11,12,14b-dodecahydro-1H-picene-2-carboxylic acid
English name
18β-Glycyrrhetinic Acid
Molecular formula
C30H46O4
Molecular weight
470.68

Names & synonyms

enoxolone471-53-4Glycyrrhetic acidGLYCYRRHETINIC ACIDUralenic acid18-beta-Glycyrrhetinic acidJintanRhetinic AcidEnoxolonaEnoxolonum3beta-Hydroxy-11-oxoolean-12-en-30-oic acidDTXSID9020669
Show more names
18B-GLYCYRRHETINIC ACIDGlycyrrhetinateGlycyrrhetinicbiosone18β-Glycyrrhetic acidglycyrrhetin
(2S,4aS,6aR,6aS,6bR,8aR,10S,12aS,14bR)-10-hydroxy-2,4a,6a,6b,9,9,12a-heptamethyl-13-oxo-3,4,5,6,6a,7,8,8a,10,11,12,14b-dodecahydro-1H-picene-2-carboxylic acidNSC-353473-beta-Hydroxy-11-oxoolean-12-en-30-oic acidP540XA09DROlean-12-en-29-oic acid, 3-hydroxy-11-oxo-, (3beta,20beta)-DTXCID50669CHEBI:30853Glyciram

Database identifiers

CAS
471-53-4
PubChem CID
10114
DTXSID
DTXSID9020669
ChEMBL
CHEMBL230006
ChEBI

Properties

Computed structural properties

XLogP
6.4
Topological polar surface area
74.6 Ų
Hydrogen bond donors
2
Hydrogen bond acceptors
4
Rotatable bonds
1
Heavy atoms
34
Formal charge
0
Complexity
965

Experimental & physicochemical properties

DrugsPharmaceuticals -> Listed in ZINC15
LipidsLipids -> Prenol Lipids [PR] -> Isoprenoids [PR01] -> C30 isoprenoids (triterpenes) [PR0106]
Cosmetics · 3 items

Cosmetic ingredients (Glycyrrhetinic Acid) -> CIR (Cosmetic Ingredient Review)

Skin conditioning

Personal care product -> emollient

Collision Cross Section · 2 items

223.01 Ų [M+K]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]

213.9 Ų [M+H]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]

Physicochemical properties

Melting point
292 · 292-295 °C(lit.)
alpha
165 · 165 º (c=1, CHCl3,on dry ba)
Boiling point
492.11 °C · 492.11°C (rough estimate)
Density
0.9967 · 0.9967 (rough estimate)
vapor pressure
10 · 10-220Pa at 20-50℃

Safety & regulation

Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.

GHS classification

GHS Classification · 5 items

This chemical does not meet GHS hazard criteria for 35.6% (26 of 73) of reports.

Warning

H302 (64.4%): Harmful if swallowed [Warning Acute toxicity, oral]

P264, P264+P265, P270, P280, P301+P317, P305+P351+P338, P330, P337+P317, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 73 reports by companies from 5 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

Hazard information

Regulatory Information · 3 items

Chemical: Olean-12-en-29-oic acid, 3-hydroxy-11-oxo-, (3.beta.,20.beta.)-

REACH registered substance: Enoxolone (EC: 207-444-6)

Olean-12-en-29-oic acid, 3-hydroxy-11-oxo-, (3.beta.,20.beta.)-: Does not have an individual approval but may be used under an appropriate group standard

Hazard Classes and CategoriesAcute Tox. 4 (64.4%)

Toxicology

Toxicity SummarySafe in the present practices of use and concentration. Ingredient, concentration, and use information are available in documents discoverable at https://cir-reports.cir-safety.org

Safety data

PPE
dust mask type N95 (US), Eyeshields, Gloves
wgk
3
tsca
TSCA listed
rtecs
RK0180000
hs_code
29189900

Chemistry & industry

Pharmacology

ATC Code · 2 items

D - Dermatologicals

QD - Dermatologicals

MeSH Pharmacological ClassificationSubstances that reduce or suppress INFLAMMATION.

Uses & manufacturing

UsesCIR ingredient: Glycyrrhetinic Acid
Use ClassificationCosmetics -> Skin conditioning
General Manufacturing InformationOlean-12-en-29-oic acid, 3-hydroxy-11-oxo-, (3.beta.,20.beta.)-: ACTIVE
Applications · 9 items

DescriptionExtracting from liquorice (Glycyrrhiza uralensis Fisch, Gan Cao), glycyrrhetic acid also can be detected in other plants, such as Abrus cantoniensis Hance and Herba Abri fruticulosi. As one of traditional Chinese medicines, liquorice has been applied clinically for a long period. Due to its extensive usage, it plays an extremely important role in traditional Chinese medicine formula mainly as “guide” drug. As is recorded in Shen Nong’s Herbal Classic and later in pharmaceutical monographs, liquorice is able to strengthen bones and muscles and enhance metabolism and detoxification. Also, abnormal symptoms of the body and wound can be improved. Glycyrrhetic acid, the most important and potent ingredient of liquorice, has been recorded in Pharmacopoeia of the People’s Republic of China.

Description18β-Glycyrrhetinic acid is a major metabolite of glycyrrhizin , one of the main constituents of licorice. Both 18β-glycyrrhetinic acid and glycyrrhizin have been shown to exhibit anti-ulcerative, anti-inflammatory, and immunomodulatory properties. 18β-Glycyrrhetinic acid is an inhibitor of the complement pathway (IC50 = 35 μM). At 100 mg/kg/day, 18β-glycyrrhetinic acid is protective against diabetes complications by reducing lipid peroxidation and increasing antioxidant activity in diabetic rats. 18β-Glycyrrhetinic acid inhibits mammalian DNA polymerases α, γ, κ, and λ with IC50 values of 16.1, 19.3, 15.8, and 13.7 μM, respectively. At 100-200 μM, 18β-glycyrrhetinic acid suppresses LPS-induced TNF-α production and NF-κB activation in mouse macrophages.

Suppliers

Loading…

Open inquiries

Loading…

Related reactions

0 records
New reaction record

No reaction records under the current filter.

Compound notes

Loading…

On this pageBasic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
CHEBI:30853
UNII
P540XA09DR
EC Number
207-444-6
Nikkaji
J5.943I
refractive index
162 ° · 162 ° (C=1, MeOH)
storage temp.
2 · 2-8°C
solubility
Practically insoluble in water, soluble in ethanol, sparingly soluble in methylene chloride.
pka
5.56 · pKa 5.56±0.1 (Uncertain)
form
Crystalline Powder
color
White to off-white
optical activity
22 · [α]22/D +170.0°, c = 1 in chloroform
Water Solubility
SOLUBLE IN ACETIC ACID
Merck
14 · 14,3590
BRN
2229654 · 2229654
Cosmetics Ingredients Functions
SKIN CONDITIONING
Cosmetic Ingredient Review (CIR)
18 · 18β-Glycyrrhetinic Acid (471-53-4)
InChIKey
MPDGHEJMBKOTSU-YKLVYJNSSA-N
SMILES
CC1(C)[C@@H](O)CC[C@@]2(C)[C@H]1CC[C@]3(C)[C@@H]2C(=O)C=C4[C@@H]5C[C@](C)(CC[C@]5(C)CC[C@@]34C)C(O)=O
LogP
4.5 at · 4.5 at 20℃
CAS DataBase Reference
471 · 471-53-4(CAS DataBase Reference)
EWG's Food Scores
1 · 1
FDA UNII
540 XA09DR · P540XA09DR
ATC code
3 AX10 · D03AX10
EPA Substance Registry System
Enoxolone (471-53-4)
UNSPSC Code
41116107 · 41116107
NACRES
24 · NA.24
Symbol(GHS)
7 · GHS07
Signal word
Warning
Hazard statements
319 · H319-H302
Precautionary statements
264 · P264-P280-P305+P351+P338-P337+P313P-P264-P270-P301+P312-P330-P501
PPE
95 · dust mask type N95 (US), Eyeshields, Gloves
Hazard Codes
Xn
Risk Statements
22 · 22-36
Safety Statements
22 · 22-24/25
WGK Germany
3 · 3
RTECS
180000 · RK0180000
TSCA
TSCA listed
HS Code
29189900 · 29189900
Storage Class
11 · 11 - Combustible Solids
Toxicity
50 · mouse,LD50,intraperitoneal,308mg/kg (308mg/kg),Drugs in Japan Vol. -, Pg. 319, 1990.
REACH Registrations
Active
Toxicity
mouse,LD50,intraperitoneal,308mg/kg (308mg/kg),Drugs in Japan Vol. -, Pg. 319, 1990.
risk_code
22-36
Signal word
Warning
Symbol(GHS)
GHS07
hazard_code
Xn
safety_code
22-24/25
Storage Class
11 - Combustible Solids
Hazard statements
H319-H302
REACH Registrations
Active
Precautionary statements
P264-P280-P305+P351+P338-P337+P313P-P264-P270-P301+P312-P330-P501

HistoryGlycyrrhetic acid originates from hydrolysis of glycyrrhizin, which has a therapeutic effect on disease. Dating back to the 1930s, the chemical structure of glycyrrhetic acid was demonstrated . Subsequently, the discovery of antiulcer activity promotes following research . The ramification of glycyrrhetic acid, carbenoxolone sodium, has a therapeutic effect on ulcer. In 2010, followed by the approval of raw materials, batches of tablets and capsules were approved in 2009, respectively. In foreign countries, 18β-glycyrrhetic acid was studied for anti-inflammatory effect on arthritis, rheumatoid disease, and periodontitis in BioNetWorks. The company applied for the patent of 18β-glycyrrhetic acid in 1999. Also, after joining the leading worldwide market in 2006, phase III clinical trials would be carried out in 2007. However, the progress was hindered in 2008. To detecting more indications, its carbenoxolone sodium was studied by other three companies: after conducting phase III clinical trials in the UK, the project of RB intending to improve nonspecific inflammatory bowel disease was given up in 1992. York Pharma expected to make progress in psoriasis with gel or cream; however, the project has been in a standstill after phase II clinical trials was conducted from 2005 to 2009. Canada pharmaceutical company, Oxalys Pharmaceuticals, research it for treating Huntington’s disease, and it was included in the orphan drug list by the USA in 2014. Till now, phase I clinical trials are still continuing.

UsesThe product may be used as a starting material to prepare 18β-glycyrrhetinic acid derivatives, which show anti-inflammatory and antioxidant properties.

UsesAn anti-inflammatory (topical).

Usesantitussive, antiinflammatory, antibacterial

UsesThe aglycone of the triterpenoid Glyccyrrhizic acid.

Usesglycyrrhetinic acid is anti-irritant, anti-allergenic, anti-inflammatory, skin-lightening, and smoothing properties are attributed to this ingredient, which is also a carrier. It is the organic compound derived from glycyrrhizic acid or shredded licorice roots.

General Description18β-Glycyrrhetinic acid is a pentacyclic triterpenoid found in the Glycyrrhiza glabra L.(liquorice) roots. It is the key metabolite of glycyrrhizin and glycyrrhizic acid.

Upstream & downstream products

Upstream raw materials

Glycyrrhizic acidSISEthanolTriammonium glycyrrhizinateSucroseDGLEthanol solution18α-GlycylrrhizinWaterHydrochloric acid

Downstream products

Stearyl glycyrrhetinate

Additional notes

DefinitionChEBI: A pentacyclic triterpenoid that is olean-12-ene substituted by a hydroxy group at position 3, an oxo group at position 11 and a carboxy group at position 30.